Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
27-29 May, 2025
Not Confirmed
Not Confirmed
27-29 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
27-29 May, 2025
Industry Trade Show
Not Confirmed
27-29 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
23 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/france-invests-eu13m-novel-mrna-project-led-ose-immunotherapeutics
05 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/05/3074333/0/en/OSE-Immunotherapeutics-Announces-90-of-Responders-Maintained-Symptomatic-Remission-Through-Extension-Period-on-Lusvertikimab.html
30 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/30/3070957/0/en/Immuno-Oncology-Results-from-Research-Collaboration-with-L%C3%A9on-B%C3%A9rard-Cancer-Center-Presented-at-AACR-Annual-Meeting-2025.html
23 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/23/3066693/0/en/OSE-Immunotherapeutics-Highlights-Abstracts-Selected-for-Presentation-at-ASCO-2025.html
26 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/26/3049997/0/en/OSE-Immunotherapeutics-Reports-Full-Year-2024-Financial-Results-and-Provides-Corporate-Update.html
11 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/11/3040906/0/en/OSE-Immunotherapeutics-and-GERCOR-Announce-Positive-Topline-Phase-2-Result-for-Clinical-Trial-TEDOPaM-Evaluating-OSE2101-Tedopi-in-Advanced-Pancreatic-Cancer.html
ABOUT THIS PAGE